The Japan's Ministry of Health, Labour and Welfare has approved Teijin Pharma's novel expectorant drug formulated as a reduced-size tablet, Mucosolvan L tablet 45 mg (ambroxol hydrochloride). Teijin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback